Advertisement
Screener

Cartesian Therapeutics, Inc. (RNAC) Pre-Tax Margin

Cartesian Therapeutics, Inc. (RNAC) Pre-Tax Margin

  • 2023-12-31: Pre-Tax Margin -2379.12%.
  • 2023-09-30: Pre-Tax Margin -137.41%.
  • 2022-12-31: Pre-Tax Margin 33.37%.
  • 2022-09-30: Pre-Tax Margin -39.66%.

Complete source-backed pre-tax margin history.

Available history
2019-12-31 to 2025-12-31
Data captured

Historical Pre-Tax Margin

DatePre-Tax Margin
2023-12-31-2379.12%
2023-09-30-137.41%
2022-12-3133.37%
2022-09-30-39.66%
2021-12-3141.34%
2021-09-30-8.46%
2020-12-31-129.24%
2020-09-30-209.41%

Annual Pre-Tax Margin

DatePre-Tax Margin
2025-12-31-34873.75%
2024-12-31-201.53%
2023-12-31-917.97%
2022-12-3131.39%
2021-12-31-11.43%
2020-12-31-414.99%
2019-12-31-828.97%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Keros Therapeutics, Inc. (KROS)United States$0.229B-2.55
SIGA TECHNOLOGIES INC (SIGA)United States$0.234B-93.33
NATURES SUNSHINE PRODUCTS INC (NATR)United States$0.228B20.51
Sionna Therapeutics, Inc. (SION)United States$0.236B-20.37
Camp4 Therapeutics Corp (CAMP)United States$0.240B-2.12
Whitehawk Therapeutics, Inc. (WHWK)United States$0.221B
MACROGENICS INC (MGNX)United States$0.242B-20.11
Cue Biopharma, Inc. (CUE)United States$0.243B-1.01
Entrada Therapeutics, Inc. (TRDA)United States$0.243B-1.73
Eledon Pharmaceuticals, Inc. (ELDN)United States$0.219B-3.23